Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/31/2012US20120136036 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
05/31/2012US20120136035 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
05/31/2012US20120136034 Fatty acids as anti-inflammatory agents
05/31/2012US20120136033 Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof
05/31/2012US20120136031 P38map kinase inhibitor
05/31/2012US20120136030 Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
05/31/2012US20120136029 Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles
05/31/2012US20120136028 Methods Of Diminishing Co-Abuse Potential
05/31/2012US20120136027 Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136025 Quinolone derivative or pharmaceutically acceptable salt thereof
05/31/2012US20120136024 3-Substituted-2-(arlyalkyl)-1-azabicycloalkanes and Methods of Use Thereof
05/31/2012US20120136023 Inhibitors of HIV Replication
05/31/2012US20120136022 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
05/31/2012US20120136021 Oxidation-stabilized tamper-resistant dosage form
05/31/2012US20120136020 Treatment of effect of chemicals with their ultradilute stereoisomers
05/31/2012US20120136019 (s)-n-methylnaltrexone
05/31/2012US20120136018 Quinolines
05/31/2012US20120136017 Use of 4'-thio-2'-deoxynucleosides as anti orthopoxvirus agents
05/31/2012US20120136016 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
05/31/2012US20120136015 Process for preparation of endothelial receptor antagonist (bosentan)
05/31/2012US20120136014 Dihydrofolate reductase inhibitors
05/31/2012US20120136013 Organic compounds
05/31/2012US20120136012 Amino tetrahydro-pyridopyrimidine pde10 inhibitors
05/31/2012US20120136011 Compounds and methods for skin repair
05/31/2012US20120136009 Indole derivative modulators of the alpha 7 nachr
05/31/2012US20120136008 Pyrido[4,3-b]indoles and methods of use
05/31/2012US20120136007 Methods and compositions for treating degenerative and ischemic disorders
05/31/2012US20120136006 Cold menthol receptor antagonists
05/31/2012US20120136005 Eltoprazine for the treatment of anxiety
05/31/2012US20120136004 New combination therapy in treatment of cancer and fibrotic diseases
05/31/2012US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
05/31/2012US20120136002 Protease inhibitors
05/31/2012US20120136001 Substituted oxindole derivatives, medicaments containing the latter and use thereof
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135999 Compounds and methods for antiviral treatment
05/31/2012US20120135998 Compounds for treating respiratory syncytial virus infections
05/31/2012US20120135997 Pharmaceutical composition comprising a lactam or benzenesulfonamide compound
05/31/2012US20120135996 Cytoprotective agent
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135993 Cyclic triazo sodium channel blockers
05/31/2012US20120135992 Cyclic triazo sodium channel blockers
05/31/2012US20120135991 Orally rapidly disintegrating tablet that contains two or more types of particles
05/31/2012US20120135990 Iap inhibitors
05/31/2012US20120135989 Azaindole derivative
05/31/2012US20120135988 Purine pi3k inhibitor compounds and methods of use
05/31/2012US20120135987 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
05/31/2012US20120135986 Bicyclic Heteroaryl Compounds
05/31/2012US20120135985 Substituted piperidines
05/31/2012US20120135984 Dual-action inhbitors and methods of using same
05/31/2012US20120135983 DNA Damage Repair Inhibitors for the Treatment of Cancer
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135981 Novel substituted triazole and imidazole derivatives as gamma secretase modulators
05/31/2012US20120135980 Gamma secretase modulators
05/31/2012US20120135979 Pyrazinooxazepine derivatives
05/31/2012US20120135978 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
05/31/2012US20120135977 Ether benzotriazole derivatives
05/31/2012US20120135976 Process for the preparation of a pharmaceutical composition comprising ezetimibe
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135973 Method for treating chronic pain
05/31/2012US20120135972 Phthalocyanine derivative consisting of a mixture of 4 isomers
05/31/2012US20120135971 Estrogen antagonists as treatments for sclerosing disorders
05/31/2012US20120135970 Compositions for preventing and treating an immune system disorder
05/31/2012US20120135969 Novel powdered crystalline medicines for inhalation
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120135967 Lpa receptor agonists and antagonists and methods of use
05/31/2012US20120135965 Amorphous fosamprenavir calcium
05/31/2012US20120135964 Certain chemical entities, compositions, and methods
05/31/2012US20120135963 Lipidated oxoadenine derivatives
05/31/2012US20120135962 Compositions to combat ectoparasites
05/31/2012US20120135961 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
05/31/2012US20120135960 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
05/31/2012US20120135959 Metalloprotein inhibitors containing nitrogen based ligands
05/31/2012US20120135958 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120135957 Compositions containing mixtures of fermentable fibers
05/31/2012US20120135956 Compositions for preventing and treating an immune system disorder
05/31/2012US20120135955 External Preparation Containing NSAIDs And Method For Producing The External Preparation
05/31/2012US20120135954 Compounds for preventing or treating viral infections and methods of use thereof
05/31/2012US20120135953 Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120135952 Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharmaceutical compositions and combinations containing same
05/31/2012US20120135951 3'-azido purine nucleotide prodrugs for treatment of viral infections
05/31/2012US20120135950 Antiviral treatment of lymphoma and cancer
05/31/2012US20120135949 Combination therapy for treating hcv infection
05/31/2012US20120135948 Antibacterial aminoglycoside analogs
05/31/2012US20120135947 Oil-in-water emulsion composition containing difluprednate and tobramycin
05/31/2012US20120135946 Antibacterial aminoglycoside analogs
05/31/2012US20120135945 Antibacterial aminoglycoside analogs
05/31/2012US20120135944 Inhibitors of bruton's tyrosine kinase
05/31/2012US20120135943 Cell protection in dialysis patients by administration of a creatine compound
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135937 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
05/31/2012US20120135930 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
05/31/2012US20120135929 Methods Of Modulating Uric Acid Levels
05/31/2012US20120135925 Covalent Inhibition of Bacterial Quorum Sensing
05/31/2012US20120135918 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
05/31/2012US20120135094 Oregano and mint anti-inflammatory compositions and methods
05/31/2012US20120135092 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
05/31/2012US20120135091 Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
05/31/2012US20120135089 E3 ligase inhibitors
05/31/2012US20120135087 Topical compositions designed to maintain or restore the integrity of the mucous membranes
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 7860